Neural Regeneration Research

Neural Regeneration Research is a peer-reviewed open access journal published by Wolters Kluwer Medknow Publications since 2006 under the ISSN 1673-5374 and eISSN 1876-7958, covering neural regeneration and repair at the molecular, cellular and system levels, with a 2025 Journal Impact Factor of 8.5 and first quartile ranks of 35 of 207 in cell biology and 20 of 330 in neurosciences《神经再生研究》（Neural Regeneration Research）是沃尔特斯克鲁沃美知出版社（Wolters Kluwer Medknow Publications）自 2006 年起出版的同行评审开放获取期刊，刊号 1673-5374、电子刊号 1876-7958，覆盖分子、细胞与系统层面的神经再生与修复，2025 年影响因子为 8.5，在细胞生物学类 207 种期刊中列第 35 位、在神经科学类 330 种期刊中列第 20 位，均居第一四分位。

Scope

• The journal publishes original research, reviews and perspectives on neural regeneration and repair, covering the molecular, cellular, circuit and system levels of nervous system recovery after injury or disease该刊刊载神经再生与修复的原创研究、综述与观点，覆盖损伤或疾病后神经系统恢复的分子、细胞、回路与系统层面。
• It covers neural stem cells and progenitor cells, neurogenesis, axon regeneration and guidance, synaptogenesis and circuit reformation, remyelination, and the plasticity of neural circuits after injury该刊覆盖神经干细胞与祖细胞、神经发生、轴突再生与导向、突触形成与回路重建、髓鞘再生，以及损伤后神经回路的可塑性。
• The journal addresses the molecular and cellular mechanisms of neural regeneration including growth factors, signalling pathways, gene regulation, inflammation and the immune response in the injured nervous system, and glial cell responses to injury该刊涉及神经再生的分子与细胞机制，包括生长因子、信号通路、基因调控、损伤神经系统中的炎症与免疫响应，以及胶质细胞对损伤的响应。
• It also covers translational and clinical research including biomaterials and tissue engineering for neural repair, cell and gene therapy for neurological disease, neurorehabilitation, and clinical trials of regenerative interventions for spinal cord injury, stroke and neurodegenerative disease该刊亦覆盖转化与临床研究，包括神经修复的生物材料与组织工程、神经疾病的细胞与基因治疗、神经康复，以及脊髓损伤、卒中与神经退行性疾病的再生干预临床试验。
• As an open access journal it applies a Creative Commons licence to accepted articles and levies an article processing charge on the corresponding author, and it operates single-blind peer review作为开放获取期刊，该刊对录用文章采用知识共享许可，向通讯作者收取文章处理费，实行单盲同行评审。
• In the 2025 Journal Citation Reports it ranks 35 of 207 in cell biology and 20 of 330 in neurosciences, with five year indicators in the first quartile for both categories在 2025 年版期刊引证报告中，该刊在细胞生物学类 207 种期刊中列第 35 位、在神经科学类 330 种期刊中列第 20 位，两类五年指标均居第一四分位。

History

• The journal was launched in 2006 by Wolters Kluwer Medknow Publications as an open access title dedicated to neural regeneration, and it has operated as a fully open access journal since its first volume该刊于 2006 年由沃尔特斯克鲁沃美知出版社（Wolters Kluwer Medknow Publications）创刊，作为神经再生的专门开放获取期刊，自第一卷起即为完全开放获取。
• It has been published monthly throughout most of its history, with twelve issues per volume per year, and it is one of the leading titles dedicated to neural regeneration and repair该刊历史上大部分时间以月刊形式出版，每年一卷十二期，是神经再生与修复领域的主要期刊之一。
• The Journal Impact Factor moved from 5.135 in 2021 to 6.058 in 2022, then to 6.7 in 2024 and to 8.5 in 2025, maintaining first quartile standing in cell biology and neurosciences throughout该刊影响因子由 2021 年的 5.135 升至 2022 年的 6.058，再升至 2024 年的 6.7 与 2025 年的 8.5，始终居细胞生物学类与神经科学类第一四分位。
• The journal has progressively expanded its coverage to address biomaterials and tissue engineering for neural repair, optogenetics and chemogenetics, organoids and the application of machine learning to neural regeneration data, reflecting the translational and interdisciplinary turn in the field该刊逐步扩展覆盖以纳入神经修复的生物材料与组织工程、光遗传学与化学遗传学、类器官及机器学习在神经再生数据中的应用，反映该领域的转化与跨学科转向。
• The publisher carries the journal on its medical publishing platform and the digital object identifier prefix of its articles is 10.4103, shared with other Wolters Kluwer Medknow titles出版方将该刊载于其医学出版平台，其文章的数字对象唯一标识符前缀为（10.4103），与沃尔特斯克鲁沃美知其他期刊一致。

Editors

• The journal is led by an editor-in-chief supported by an editorial board whose members are drawn from neuroscience, neurology, cell biology, biomaterials and rehabilitation medicine departments across the world, with strong representation from China该刊由一位主编带领，配以由世界各地神经科学、神经病学、细胞生物学、生物材料与康复医学科的学者组成的编委会，中国学者占重要比例。
• The editorial team includes associate editors responsible for subject areas such as neural stem cells, axon regeneration, biomaterials for neural repair, neurorehabilitation and clinical trials, reflecting the breadth of neural regeneration research编辑团队设有副编辑，分别负责神经干细胞、轴突再生、神经修复生物材料、神经康复与临床试验等方向，对应神经再生研究的广度。
• Editorial handling follows the Wolters Kluwer editorial management system, with submissions assigned to handling editors based on subject expertise and competing interest declarations稿件处理依托沃尔特斯克鲁沃的编辑管理系统，依据学科专长与利益冲突声明分配责任编辑。
• Peer review is single-blind and the journal maintains the Wolters Kluwer Medknow standards on reviewer recruitment, conflict of interest management, data sharing and editorial independence同行评审采用单盲方式，该刊遵循沃尔特斯克鲁沃美知在审稿人遴选、利益冲突管理、数据共享与编辑独立性方面的标准。
• The masthead and board roster are published on the journal page and updated as new members join or existing members step down编委名单在期刊页公布，并随成员增减而更新。